Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.103
Schlusskurs vom Vortag:
$0.103
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$14.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-119.76M
KGV:
0.00
EPS:
-1.35
Netto-Cashflow:
$-55.17M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$1.50
Applied Therapeutics Inc Stock (APLT) Company Profile
Firmenname
Applied Therapeutics Inc
Sektor
Branche
Telefon
212-220-9226
Adresse
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Compare APLT vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.00 | 14.86M | 0 | -119.76M | -55.17M | -1.35 |
VRTX
Vertex Pharmaceuticals Inc
|
447.26 | 113.44B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
777.25 | 81.68B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
743.12 | 45.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.73 | 43.88B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.86 | 35.25B | 606.42M | -1.28B | -997.58M | -6.403 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-12-03 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-23 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | Eingeleitet | William Blair | Outperform |
| 2024-03-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-22 | Eingeleitet | Leerink Partners | Outperform |
| 2022-01-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-08-27 | Herabstufung | Goldman | Neutral → Sell |
| 2021-06-25 | Fortgesetzt | Goldman | Neutral |
| 2020-10-08 | Eingeleitet | Truist | Buy |
| 2020-04-22 | Eingeleitet | Goldman | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-06-10 | Eingeleitet | Citigroup | Buy |
| 2019-06-10 | Eingeleitet | Cowen | Outperform |
| 2019-06-10 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Applied Therapeutics Inc Aktie (APLT) Neueste Nachrichten
Earnings Report: Can Applied Therapeutics Inc continue delivering strong returns2026 Opening Moves & High Accuracy Buy Signal Tips - baoquankhu1.vn
Published on: 2026-03-31 11:48:00 - baoquankhu1.vn
Sentiment Recap: Can Applied Therapeutics Inc continue delivering strong returns2026 Market Mood & Smart Swing Trading Alerts - baoquankhu1.vn
Panic Selling: Can Applied Therapeutics Inc keep up with sector leaders2026 Technical Patterns & Verified Technical Trade Signals - baoquankhu1.vn
Published on: 2026-03-25 10:49:57 - baoquankhu1.vn
Applied Therapeutics shifts social media operations to Cycle Pharmaceuticals - Traders Union
If You Invested $1,000 in Applied Therapeutics (APLT) - Stock Titan
Sentiment Review: Is Applied Therapeutics Inc gaining market share2026 Update & Accurate Intraday Trade Tips - baoquankhu1.vn
Sectors Review: Is Applied Therapeutics Inc backed by strong institutional buyingWeekly Risk Report & Verified Short-Term Trading Plans - baoquankhu1.vn
AI Stocks: Should I set a stop loss on Applied Therapeutics IncProduct Launch & Smart Allocation Stock Reports - baoquankhu1.vn
Here's why Applied Therapeutics (APLT) is a great 'buy the bottom' stock now - MSN
Aug Highlights: Is Applied Therapeutics Inc stock good for income investors2025 Price Targets & Community Consensus Trade Signals - baoquankhu1.vn
APLT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Momentum Shift: How does Applied Therapeutics Inc score in quality rankings2025 Market Overview & Growth Oriented Trading Recommendations - baoquankhu1.vn
Should you buy the dip on Applied Therapeutics Inc.Watch List & High Accuracy Buy Signal Tips - mfd.ru
IPO Launch: Can Applied Therapeutics Inc keep up with sector leadersDollar Strength & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Can Applied Therapeutics Inc. keep up with sector leadersMarket Sentiment Review & Smart Allocation Stock Reports - mfd.ru
[15-12G] Applied Therapeutics, Inc. SEC Filing - Stock Titan
Will Applied Therapeutics Inc. stock benefit from sector rotationJuly 2025 Intraday Action & Community Shared Stock Ideas - mfd.ru
Highs Report: What are Applied Therapeutics Incs recent SEC filings showing2025 Price Action Summary & Technical Pattern Based Signals - baoquankhu1.vn
Aug Mood: Is VivoSim Labs Inc benefiting from innovation trendsQuarterly Market Summary & Pattern Based Trade Signal System - baoquankhu1.vn
Cycle Group acquires Applied Therapeutics to expand rare disease portfolio By Investing.com - Investing.com Nigeria
Applied Therapeutics completes merger and Nasdaq delisting move - The Globe and Mail
Cycle Group Holdings Limited completed the acquisition of Applied Therapeutics, Inc.. - marketscreener.com
Applied Therapeutics completes merger with Cycle Group Holdings, delists from Nasdaq - Investing.com
Cycle Group Holdings Acquires Applied Therapeutics - Contract Pharma
Cycle Group acquires Applied Therapeutics to expand rare disease portfolio - Investing.com
Applied Therapeutics Announces Board and Management Changes Following Merger - TradingView
Applied Therapeutics, Inc. Announces Management Changes - marketscreener.com
Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics - Business Wire
Sectors Review: Will Applied Therapeutics Inc benefit from seasonalityGap Up & Expert Curated Trade Ideas - baoquankhu1.vn
Earnings Recap: Can EFCPRA reach all time highs this yearRate Cut & Smart Swing Trading Techniques - baoquankhu1.vn
APLT Stock Price, Quote & Chart | APPLIED THERAPEUTICS INC (NASDAQ:APLT) - ChartMill
Published on: 2026-02-01 03:43:48 - baoquankhu1.vn
Retail Traders Cheer Applied Therapeutics Data On Rare Nerve Disease Drug - MSN
Cycle Pharmaceuticals Announces Further Extension of Applied Therapeutics Tender Offer - marketscreener.com
Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer - Business Wire
Cycle extends tender offer deadline for Applied Therapeutics acquisition By Investing.com - Investing.com Nigeria
What chart patterns are forming on Applied Therapeutics Inc.Layoff News & Detailed Earnings Play Alerts - mfd.ru
Applied Therapeutics (APLT) Updates on Cycle Group's Acquisition Offer - GuruFocus
Cycle extends tender offer deadline for Applied Therapeutics acquisition - Investing.com
Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension - The Manila Times
Applied Therapeutics (NASDAQ: APLT) extends tender offer, 44% of shares tendered - Stock Titan
Applied Therapeutics Announces Extension of Tender Offer by Cycle Group Holdings for Acquisition | APLT Stock News - Quiver Quantitative
Applied Therapeutics Shares Letter to Stockholders - GlobeNewswire
Applied Therapeutics warns: tender now or risk getting nothing - stocktitan.net
Acquisition of Applied Therapeutics Nears Finalization - AD HOC NEWS
Cycle Pharmaceuticals Extends Tender Offer for Applied Therapeutics - National Today
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) - GuruFocus
Applied Therapeutics chief medical officer sells $52,507 in stock - MSN
Will Applied Therapeutics Inc. stock see insider buyingSector Performance Drivers & Free Take Advantage Of Momentum - Bollywood Helpline
Finanzdaten der Applied Therapeutics Inc-Aktie (APLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.52%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):